🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Drugs used in chemotherapy, such as doxorubicin hydrochloride, b...
Status
Terminated
Location
Stanford Cancer Center
Start Date
2013-05-24
Trial ID
NCT01390584
The purpose of this study is to find out whether N10 chemotherapy is a safe...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2024-07-22
Trial ID
NCT06528496
Prospective single arm study to evaluate a low-dose CT-based protocol for e...
Status
Completed
Location
University of California San Diego Medical Center
Start Date
2018-01-09
Trial ID
NCT03553654
Treatments Being Tested
This phase IB trial studies the feasibility of using a functional laborator...
Status
Completed
Location
OHSU Knight Cancer Institute
Start Date
2016-01-13
Trial ID
NCT02779283
Treatments Being Tested
The study will include newly-diagnosed AML patients, not suffering acute pr...
Status
Unknown
Location
Weill Cornell Medicine
Start Date
2017-07-03
Trial ID
NCT03257241
Treatments Being Tested
This study will test if adding ruxolitinib to standard multi-drug chemother...
Status
Recruiting
Location
University of Chicago Medical Center
Start Date
2019-05-28
Trial ID
NCT03571321
The purpose of phase 1 part in this study was to determine the maximum tole...
Status
Completed
Location
Site JP81037
Start Date
2015-02-26
Trial ID
NCT02310321
Treatments Being Tested
H. Lee Moffitt Cancer Center and Research Institute will be the Sunshine Pr...
Status
Completed
Location
Holtz Children's Hospital University of Miami Miller School of Medicine
Start Date
2011-07-18
Trial ID
NCT01324180
Treatments Being Tested
In this prospective randomized study for patients with newly diagnosed acut...
Status
Unknown
Location
Department of Hematology
Start Date
2012-06
Trial ID
NCT01987297
Treatments Being Tested
The purpose of this study is to improve outcome of high risk neuroblastoma ...
Status
Unknown
Location
Samsung Medical Center
Start Date
2015-04
Trial ID
NCT02771743